Treating cigarette smoking with smokeless tobacco: A flawed recommendation

American Journal of Medicine

Volumn 104, Issue 5, 1998, Pages 499-500

  Jorenby, Douglas E ^a,c   Fiore, Michael C ^c   Smith, Stevens S ^a   Baker, Timothy B ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

NICOTINE;

CIGARETTE SMOKING; EDITORIAL; HEALTH CARE POLICY; PATIENT COMPLIANCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK FACTOR; SMOKELESS TOBACCO; SMOKING CESSATION; SMOKING HABIT; TREATMENT PLANNING; WITHDRAWAL SYNDROME;

HUMANS; PLANTS, TOXIC; PRACTICE GUIDELINES; RESEARCH; SMOKING; SMOKING CESSATION; TOBACCO, SMOKELESS; UNITED STATES; UNITED STATES AGENCY FOR HEALTHCARE RESEARCH AND QUALITY;

EID: 17644442278     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(98)00084-9     Document Type: Editorial

References (16)

1. 1. Tilashalski K, Rodu B, Cole P. A pilot study of smokeless tobacco in smoking cessation. Am J Med. 1998;104:456-458.
2. 2. Sachs DPL, Sawe U, Leischow SJ. Effectiveness of a 16-hour transdermal nicotine patch in a medical practice setting, without intensive group counseling. Arch Intern Med. 1993;153:1881-1890.
3. 3. Buchkremer G, Bents H, Horstrnann M, et al. Combination of behavioral smoking cessation with transdermal nicotine substitution. Addict Behav. 1989;14:229-238.
4. 4. Hurt RD, Dale LC, Fredrickson PA, et al. Nicotine patch therapy for smoking cessation combined with physician advice and nurse follow-up: one-year outcome and percentage of nicotine replacement. JAMA. 1994;271:595-600.
5. 5. Hurt RD, Sachs DPL, Glover ED, et al. A comparison of sustained-release bupropion and placebo for smoking cessation. NEJM. 1997; 337:1195-1202.
6. 6. Sutherland G, Stapleton JA, Russell MAH, et al. Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet. 1992;340:324-329.
7. 7. Warner KE, Slade J, Sweanor DT. The emerging market for long-term nicotine maintenance. JAMA. 1997;278:1087-1092.
8. 8. Winn DM. Surveillance of and knowledge about cancer associated with smokeless tobacco use. NCI Monographs. 1993;2:11-18.
9. 9. McGuirt WFT, Wray A. Oral carcinoma and smokeless tobacco use: a clinical profile. NCI Monographs. 1993;2:91-95.
10. 10. Robertson PB, Ernster V, Walsh M, et al. Periodontal effects associated with the use of smokeless tobacco: results after 1 year. NCI Monographs. 1993;2:78-86.
11. 11. Hatsukami DK, Gust SW, Keenan RM. Physiologic and subjective changes from smokeless tobacco withdrawal. Clin Pharmacol Therapeut. 1987;41:103-107.
12. 12. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking Cessation. Clinical practice guideline no. 18. Rockville, Md: US Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research. AHCPR publication no. 96-0692, April 1996.
13. 13. Jorenby DE, Keehn DS, Fiore MC. Comparative efficacy and tolerability of nicotine replacement therapies. CNS Drugs. 1995;3:227-236.
14. 14. US Department of Health and Human Services. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Washington, DC: Public Health Service, Office on Smoking and Health. DHHS publication no. 90-8416, 1990.
15. 15. Humfleet G, Hall S, Reus V, et al. The efficacy of nortriptyline as an adjunct to the psychological treatment for smokers with and without depressive histories. In: Harris LS, ed. Problems of Drug Dependence 1995. Proceedings of the 57th Annual Scientific Meeting, College on Problems of Drug Dependence, Inc. NIDA research monograph 162. Washington, DC. Government Printing Office; 1996;334. Abstract.
16. 16. TenPas WS. Smokeless tobacco. Oral Surg Oral Med Oral Path. 1996;81:376-377.